Health Technology Assessment (HTA)

Nasopharyngeal carcinoma (NPC), a formidable oncological adversary, often proves challenging to treat, especially in cases that are recurrent or have metastasized. The emergence of...

A milestone in the realm of neurodegenerative disease diagnostics, Amyvid presents a seamless fusion of radiopharmaceutical innovation and clinical precision for Alzheimer's detection. By...

A pivotal decision by Germany's Joint Federal Committee (G-BA) on January 13, 2026, revised the known annual therapy costs associated with Mirikizumab, particularly for...

The pharmaceutical landscape for ulcerative colitis (UC) treatment undergoes a significant realignment as the Joint Federal Committee (G-BA) issues an essential amendment affecting therapeutic...

In recent developments in medical technology, a novel therapy combining epidural electrical stimulation (EES) with robot-assisted rehabilitation is offering hope for patients with spinal...

In a critical move to address escalating concerns over fungal infections, the European Union has granted marketing authorization to Voriconazole Hikma, a generic antifungal...

The complexities of integrating medical technologies into hospital systems underscore the importance of Health Technology Assessment (HTA) in France. While HTA is pivotal for...

Across the UK, the conversation about healthcare prioritization has gained momentum due to new findings on public sentiment towards severity modifiers in health assessment....

In a comprehensive evaluation overseen by the Institute for Quality and Efficiency in Health Care (IQWiG) in Germany, the therapeutic potential of Tislelizumab in...

In the realm of smoking cessation, a significant development emerges with the assessment of cytisinicline at the center of attention. The Institute for Clinical...

In a world where musculoskeletal disorders (MSDs) incapacitate more than 1.7 billion individuals, revolutionary changes in therapeutic protocols are paramount. Digital therapeutics (DTx), leveraging...

The relentless advance in cancer treatment options continues to offer hope for patients, with the non-small cell lung cancer (NSCLC) sector being no exception....

Under the grandeur of Brussels' institutional legacy, a pivotal step has been embarked upon by the European BRIDGE project. This ambitious initiative formally started...

In Slovakia, the National Institute for Value and Technology in Healthcare (NIHO) takes a vital role by evaluating special medical materials for inclusion in...

The Institute for Quality and Efficiency in Health Care (IQWiG) embarks on a critical assessment of Concizumab, a promising treatment for haemophilia B, marking...